Key Sessions and Expert Interviews at the NCODA Fall Summit

Pharmacy Times® will be covering the NCODA Fall Summit in Orlando from October 23 to October 25, 2024. NCODA provides an opportunity to learn from and connect with industry experts and leaders in the field through educational sessions that provide the latest insights into patient-centered care and medically integrated oncology.

Image Credit: © Kevin Ruck - stock.adobe.com

“The NCODA International Fall Summit is a vital platform for decision-makers in oncology care to collaborate on solutions that improve access to life-saving medications and elevate operational excellence,” said Michael Reff, RPh, MBA, NCODA Executive Director and Founder. “This event allows us to exchange actionable insights that not only shape the future of oncology pharmacy but also ensure that the latest treatments are accessible to all patients, no matter where they receive care.”

Stay tuned on pharmacytimes.com for exclusive session coverage and interviews with presenters, such as:

• Interviews with Ginger Blackmon, PharmD, Associate Director of Clinical Initiatives at NCODA, and Stephanie White, PharmD, CSP from Vanderbilt University Medical Center, will be presenting on the impact of NCODA’s Positive Quality Interventions, a precise and concise peer-reviewed clinical guidance resource. They will discuss how this resource can enable clinicians to provide better care for patients with cancer.
• A session about updates in breast cancer treatment led by Joyce O'Shaughnessy, MD from Texas Oncology. She will discuss the evolving treatment landscape and advancements that provide patients with expanded therapeutic options personalized to their disease.
• An interview with Nathan Vanderford, Associate Professor of Toxicology and Cancer Biology in the College of Medicine at the University of Kentucky, will discuss cancer disparities and social determinants of health, namely those seen in Kentucky. This will act as a case study for cancer care obstacles experienced by patients in rural communities.
• A session about ensuring safety in hazardous drug compounding areas led by Liz Vogel, CPhT-Adv, CSPT from Mayo Clinic. She will share common environmental hazards interfering with safe drug compounding, as well as proper measures and best practices for health care workers.
• A session about the benefit of medically integrated teams in lung cancer treatment led by Kevin Hicks, PharmD, PhD, FCCP, from Moffitt Cancer Center; Theresa Boyle, MD, PhD, Donna Gallenstein, BSN, RN, GERO-BC; Daniel Melzer, PharmD, BCOP; and Sonam Puri, MD, from Moffitt Cancer Center. They will discuss how medically integrated systems can offer patients with lung cancer with more precise treatments.
• A session about the latest oncology drug trends led by Doug Long from Iqvia will cover the evolving landscape of cancer drugs and new options for patients.

Follow Pharmacy Times for coverage of the conference on our website and on social media for the latest updates.